GlycoMimetics Inc
GKO
Company Profile
Business description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Contact
P.O. Box 65
MonroviaMD21770
USAT: +1 240 243-1201
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
26
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,579.90 | 50.10 | 0.59% |
CAC 40 | 7,886.69 | 33.22 | 0.42% |
DAX 40 | 23,767.43 | 71.84 | 0.30% |
Dow JONES (US) | 42,654.74 | 331.99 | 0.78% |
FTSE 100 | 8,684.56 | 50.81 | 0.59% |
HKSE | 23,345.05 | 108.11 | -0.46% |
NASDAQ | 19,211.10 | 98.78 | 0.52% |
Nikkei 225 | 37,753.72 | 1.79 | -0.00% |
NZX 50 Index | 12,749.02 | 37.77 | -0.30% |
S&P 500 | 5,958.38 | 41.45 | 0.70% |
S&P/ASX 200 | 8,343.70 | 46.20 | 0.56% |
SSE Composite Index | 3,367.46 | 13.36 | -0.40% |